Is a Blood Pressure Reading of 150/90 mmHg Considered Hypertension?
Yes, a blood pressure reading of 150/90 mmHg meets the clinical criteria for hypertension—specifically, Stage 1 hypertension according to current guidelines from major international bodies, including
Yes, a blood pressure reading of 150/90 mmHg meets the clinical criteria for hypertension—specifically, Stage 1 hypertension according to current guidelines from major international bodies, including the American College of Cardiology (ACC) and American Heart Association (AHA), as well as the European Society of Cardiology (ESC).
This reading indicates a systolic pressure of 150 mmHg—the force exerted by blood against arterial walls during heart contraction—and a diastolic pressure of 90 mmHg—the pressure present when the heart is at rest between beats. According to the 2017 ACC/AHA guideline, hypertension is defined as a systolic blood pressure ≥130 mmHg *or* a diastolic blood pressure ≥80 mmHg, confirmed through repeated measurements on at least two separate occasions. A consistent reading of 150/90 mmHg therefore falls within the Stage 1 range (systolic 130–139 mmHg *or* diastolic 80–89 mmHg) or, depending on measurement context and patient risk profile, may be classified as Stage 2 (systolic ≥140 mmHg *or* diastolic ≥90 mmHg) under certain protocols.
It is critical to emphasize that diagnosis requires proper technique: measurements should be taken after five minutes of seated rest, using an appropriately sized cuff, with the arm supported at heart level, and averaged across multiple readings on different days. White-coat hypertension, masked hypertension, and measurement error must be ruled out before confirming a diagnosis. Ambulatory or home blood pressure monitoring may be recommended for further evaluation.
Management depends on overall cardiovascular risk. For otherwise healthy adults under age 65, lifestyle modifications—including sodium reduction, increased potassium intake, regular aerobic exercise, weight management, moderation of alcohol, and smoking cessation—are first-line interventions. Pharmacologic treatment is typically initiated in patients with established cardiovascular disease, chronic kidney disease, diabetes, or high 10-year atherosclerotic cardiovascular disease (ASCVD) risk—even at Stage 1 levels—or in those whose blood pressure remains elevated despite three to six months of lifestyle intervention.
A sustained reading of 150/90 mmHg warrants prompt clinical assessment—not only to confirm the diagnosis but also to evaluate for target organ damage (e.g., left ventricular hypertrophy, retinopathy, microalbuminuria) and identify secondary causes such as renal artery stenosis, primary aldosteronism, or obstructive sleep apnea.